SCHEMBL4369710

SCHEMBL4369710

CC(C)(Cc1cccc(-c2cccc(F)c2F)n1)OC(=O)N1CCNCC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CXCR2 P25025 1/20 0.37
▸ HRH4 Q9H3N8 1/20 0.35
▸ GPR119 Q8TDV5 2/20 0.35
▸ FAAH O00519 1/20 0.35
▸ KDM1A O60341 1/20 0.34
▸ HTR2C P28335 1/20 0.34
▸ CCNT1 O60563 2/20 0.33
▸ CDK9 P50750 1/20 0.33
▸ PIM1 P11309 1/20 0.33
▸ PIM3 Q86V86 1/20 0.33
▸ PIM2 Q9P1W9 1/20 0.33
▸ CHRM3 P20309 1/20 0.33
▸ CTSA P10619 1/20 0.33
▸ BDKRB1 P46663 1/20 0.33
▸ TRPV3 Q8NET8 1/20 0.33
▸ PARP1 P09874 1/20 0.32
▸ HTR1A P08908 1/20 0.32
▸ SLC6A2 P23975 1/20 0.32
▸ SLC6A4 P31645 1/20 0.32
▸ SLC6A3 Q01959 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4358423 0.87 FAAH (0.40) HRH4GPR119FAAHCCNT1CDK9
SCHEMBL4363957 0.83 P2RY12 (0.41) —
SCHEMBL4360123 0.79 FAAH (0.38) HRH4FAAHKDM1APARP1HTR1A
SCHEMBL30254155 0.74 ALDH1A1 (0.45) GPR119SLC6A4KDM4EALDH1A1
SCHEMBL4369708 0.73 FAAH (0.37) FAAHCCNT1CDK9CHRM3CTSA
SCHEMBL3268524 0.72 CKS1B (0.48) CXCR2GPR119FAAHALDH1A1
SCHEMBL29155320 0.70 SIGMAR1 (0.45) GPR119KDM4E
SCHEMBL4372425 0.67 FAAH (0.40) GPR119FAAHCCNT1CDK9PARP1
SCHEMBL30020659 0.67 NAMPT (0.46) GPR119KDM4EALDH1A1
SCHEMBL7383181 0.67 CYP3A4 (0.40) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090163508-A1 AMIDE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-06-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163508-A1 AMIDE COMPOUND FAAH, FAAH2, NAAA CXCR2 509/4885HRH4 24/4885GPR119 996/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback